Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2020/138824PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MALE SEXUAL DYSFUNCTION
WO 02.07.2020
Int.Class A61K 36/15
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
13Coniferophyta (gymnosperms)
15Pinaceae (Pine family), e.g. pine or cedar
Appl.No PCT/KR2019/017959 Applicant WELLNESSBIO INC. Inventor CHANG, Si-young
The present invention relates to a composition and health functional food for preventing or treating male sexual dysfunction, which include, as an active ingredient, oil separated from a Pinus densiflora extract, oil separated from an Abies holophylla Maxim extract, or a mixture thereof. The composition according to the present invention has an excellent ability to enhance penile erectility, and may be usefully applied to a health food for alleviating erectile dysfunction symptoms or a therapeutic agent for erectile dysfunction.
2.WO/2020/136593HERBAL PREPARATION-ENRICHED CANNABINOID COMPOSITION AND METHOD OF TREATMENT
WO 02.07.2020
Int.Class A61K 36/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Appl.No PCT/IB2019/061354 Applicant BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. Inventor RAZ, Noa
Described is a therapeutic product comprising: at least one cannabinoid in a specific amount and at least one herbal preparation in a specific amount, wherein said herbal preparation is produced by at least one of distilling and extracting a portion of a plant, wherein said plant is not cannabis sativa. Also described are methods for using the product and methods for producing the product.
3.WO/2020/137659COMPOSITION FOR SUPPRESSING INCREASES IN BLOOD SUGAR LEVEL/FOR SUPPRESSING INCREASES IN BLOOD TRIGLYCERIDES
WO 02.07.2020
Int.Class A61K 31/722
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716Glucans
722Chitin; Chitosan
Appl.No PCT/JP2019/049186 Applicant FANCL CORPORATION Inventor KUBOTA Yoshiko
The present invention addresses the problem of providing a novel composition for suppressing post-meal increases in blood sugar level and/or for suppressing post-meal increases in blood triglycerides. Provided is a composition for suppressing post-meal increases in blood sugar level and/or for suppressing post-meal increases in blood triglycerides that contains tea flower extract, mulberry leaf extract, and chitosan as active ingredients.
4.WO/2020/137687CORE BODY TEMPERATURE IMPROVING AGENT
WO 02.07.2020
Int.Class A61P 3/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
Appl.No PCT/JP2019/049370 Applicant KOBAYASHI PHARMACEUTICAL CO., LTD. Inventor MATSUMURA,Haruka
[Problem] The purpose of the present invention is to provide a core body temperature improving agent that improves low core body temperatures. [Solution] A core body temperature improvement agent capable of improving low core body temperature and including (A) powdered Angelica acutiloba and/or an Angelica acutiloba extract, (B) powdered Cnidium officinale Makino and/or a Cnidium officinale Makino extract, (C) powdered Paeonia lactiflora and/or a Paeonia lactiflora extract, and (D) powdered Paeonia × suffruticosa bark and/or a Paeonia × suffruticosa bark extract.
5.WO/2020/137975METHOD FOR PRODUCING XANTHOHUMOL-CONTAINING COMPOSITION
WO 02.07.2020
Int.Class A61K 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
12Ketones
Appl.No PCT/JP2019/050366 Applicant SUNTORY HOLDINGS LIMITED Inventor HATA, Yuto
The present invention relates to a method for producing a xanthohumol-containing composition, the method comprising the steps of: bringing a first mixture containing a hop-derived component containing xanthofumol and a first solvent containing water and a water miscible solvent into contact with polyvinylpolypyrrolidone to adsorb xanthofumol on the polyvinylpolypyrrolidone; washing the xanthofumol-adsorbed polyvinylpolypyrrolidone with a second solvent; and eluting xanthofumol with a third solvent from the polyvinylpolypyrrolidone to obtain a xanthofumol-containing eluate. The second solvent is an ethanol aqueous solution. The third solvent is an ethanol aqueous solution having a higher concentration than the second solvent or ethanol.
6.WO/2020/136221USE OF SECOIRIDOIDS FOR THE TREATMENT OF OPTIC NEURITIS
WO 02.07.2020
Int.Class A61K 31/222
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
222with compounds having aromatic groups, e.g. dipivefrine, ibopamine
Appl.No PCT/EP2019/087044 Applicant CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) Inventor GUTIERREZ MIRANDA, Beatriz
The present invention relates to the use of the secoiridois oleacein and oleocanthal to prevent or treat neuropathies that conduct to optic nerve injury such as optic neuritis. Also, the present invention relates to pharmaceutical composition or nutraceutical composition comprising said secoiridois.
7.WO/2020/139230CHEWABLE TABLET COMPRISING CINNAMON AND CAROB
WO 02.07.2020
Int.Class A61K 36/54
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
54Lauraceae (Laurel family), e.g. cinnamon or sassafras
Appl.No PCT/TR2019/050675 Applicant ÖZALP, Yıldız Inventor ÖZALP, Yıldız
The invention is related to a chewable tablet comprising cinnamon and/or carob. Ludipress LCE (96.5% Lactose and 3.5% Povidone) which was determined surprisingly to be ineffective to the blood glucose levels has been used in the composition of chewable tablets. Both of the natural products are crushed and than sieved and the part within a certain particle range less than 0,710 µm has been compressed by direct compression method with the filler agent Ludipress LCE.
8.WO/2020/139310"CANDOPRIMAVAC" INACTIVATED LIQUID VACCINE AGAINST CANDIDIASIS, METHOD FOR PRODUCTION THEREOF AND METHOD OF TREATMENT AND PROPHYLAXIS USING SAME
WO 02.07.2020
Int.Class A61K 36/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
Appl.No PCT/UA2019/000164 Applicant MARKOV, Ihor Semenovych Inventor MARKOV, Ihor Semenovych
The group of inventions relates to medical microbiology and the pharmaceutical industry, and more particularly to vaccine preparations and to methods for the production and use thereof, and can be used for the treatment and prophylaxis of localised and systemic Candida-associated lesions. Moreover, the vaccine comprises no less than 14 strains of 3 species of Candida fungi, namely: Candida albicans - 7, Candida krusei - 4, Candida glabrata - 3 of different locations, isolated from various fungal lesions on the skin, mucosa and internal organs, inter alia, Candida fungi strains with various degrees of resistance to antifungal drugs, and which are deposited at the Depository of the Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine.
9.WO/2020/136648CANNABIDIOLIC ACID ESTERS FOR COSMETIC OR EDIBLE COMPOSITIONS
WO 02.07.2020
Int.Class A61K 31/192
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
192having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Appl.No PCT/IL2019/051408 Applicant EPM GROUP INC. Inventor SWISA, Reshef
The present invention provides cosmetic or edible compositions comprising a cannabinoid component, wherein the cannabinoid component comprises a cannabidiolic acid (CBDA) ester alone or in combination with one or more cannabinoid compound(s), and a physiologically acceptable carrier, excipient or diluent, and uses thereof for improving appearance, well-being and/or general health.
10.WO/2020/138899COMPOSITION FOR PREVENTION OR TREATMENT OF BONE DISEASES OR CLIMACTERIC DISEASES COMPRISING SALICORNIA SPP. EXTRACT
WO 02.07.2020
Int.Class A61K 36/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
Appl.No PCT/KR2019/018359 Applicant INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY Inventor PARK, Jong Hwan
The present invention relates to a pharmaceutical composition comprising a Salicornia spp. extract for the prevention or treatment of bone diseases or climacteric diseases. Specifically, a composition containing a Salicornia spp. extract, which is a natural raw material, is prepared, and the composition can be applied as a pharmaceutical composition for the prevention or treatment of bone diseases or climacteric diseases, which can be safely used in a human body without toxicity and side effects, or a health functional food for the prevention or alleviation of bone diseases or climacteric diseases.